Geode Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.1M | Buy |
|
|||||
|
2025
Q1 | $116M | Buy |
|
|||||
|
2024
Q4 | $208M | Buy |
|
|||||
|
2024
Q3 | $212M | Buy |
|
|||||
|
2024
Q2 | $261M | Buy |
|
|||||
|
2024
Q1 | $197M | Buy |
|
|||||
|
2023
Q4 | $142M | Buy |
|
|||||
|
2023
Q3 | $171M | Buy |
|
|||||
|
2023
Q2 | $159M | Buy |
|
|||||
|
2023
Q1 | $174M | Buy |
|
|||||
|
2022
Q4 | $158M | Buy |
|
|||||
|
2022
Q3 | $128M | Buy |
|
|||||
|
2022
Q2 | $85.4M | Sell |
|
|||||
|
2022
Q1 | $89.7M | Buy |
|
|||||
|
2021
Q4 | $102M | Buy |
|
|||||
|
2021
Q3 | $91.1M | Buy |
|
|||||
|
2021
Q2 | $76.5M | Buy |
|
|||||
|
2021
Q1 | $72.2M | Buy |
|
|||||
|
2020
Q4 | $160M | Buy |
|
|||||
|
2020
Q3 | $124M | Sell |
|
|||||
|
2020
Q2 | $143M | Buy |
|
|||||
|
2020
Q1 | $83.2M | Buy |
|
|||||
|
2019
Q4 | $101M | Buy |
|
|||||
|
2019
Q3 | $57.1M | Buy |
|
|||||
|
2019
Q2 | $113M | Buy |
|
|||||
|
2019
Q1 | $82.6M | Buy |
|
|||||
|
2018
Q4 | $71.9M | Buy |
|
|||||
|
2018
Q3 | $95.5M | Buy |
|
|||||
|
2018
Q2 | $76.3M | Sell |
|
|||||
|
2018
Q1 | $42.9M | Buy |
|
|||||
|
2017
Q4 | $31.1M | Buy |
|
|||||
|
2017
Q3 | $24.8M | Buy |
|
|||||
|
2017
Q2 | $15M | Buy |
|
|||||
|
2017
Q1 | $12.5M | Buy |
|
|||||
|
2016
Q4 | $10.7M | Buy |
|
|||||
|
2016
Q3 | $21.5M | Buy |
|
|||||
|
2016
Q2 | $5.61M | Buy |
|
|||||
|
2016
Q1 | $5.51K | Sell |
|
|||||
|
2015
Q4 | $11M | Buy |
|
|||||
|
2015
Q3 | $8.03M | Buy |
|
|||||
|
2015
Q2 | $7.41M | Buy |
|
|||||
|
2015
Q1 | $2.98M | Buy |
|
|||||
|
2014
Q4 | $3.15M | Buy |
|
|||||
|
2014
Q3 | $4.55M | Sell |
|
|||||
|
2014
Q2 | $6.49M | Buy |
|
|||||
|
2014
Q1 | $4.63M | Buy |
|
|||||
|
2013
Q4 | $3.5M | Buy |
|
|||||
|
2013
Q3 | $6.79M | Buy |
|
|||||
|
2013
Q2 | $4.77M | Buy |
|